Wedbush Upgrades Nu Skin To Outperform

According to Wedbush, Nu Skin Enterprises NUS price target is raised to $48. Wedbush said that it is upgrading NUS to Outperform. “Given potential multiple expansion as expected success of major upcoming product launches should further solidify Nu Skin's reputation as a successful innovator in the global direct-selling industry, we believe shares of NUS should trade at a 20% premium to the peer group average.” Nu Skin Enterprises closed yesterday at $41.47.
Market News and Data brought to you by Benzinga APIs
Comments
Loading...
date
ticker
name
Price Target
Upside/Downside
Recommendation
Firm
Posted In: Analyst ColorUpgradesPrice TargetAnalyst RatingsConsumer StaplesPersonal ProductsWedbush
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!